Jefferies Financial Group Inc. Takes $2.79 Million Position in Alignment Healthcare, Inc. $ALHC

Key Points

• Jefferies Financial Group acquired 117,396 Alignment Healthcare shares worth approximately $2.79 million, while institutional investors collectively own 86.19% of the company.
• Analyst sentiment remains favorable but mixed: seven analysts rate ALHC a Buy and four rate it Hold, producing a “Moderate Buy” consensus and a $23.60 average price target.
• Alignment Healthcare exceeded quarterly expectations, reporting $0.17 in EPS and $1.34 billion in revenue, with revenue rising 31.6% year over year; however, insiders have sold more than 1 million shares over the past 90 days.

Jefferies Financial Group Inc. acquired a new position in shares of Alignment Healthcare, Inc. (NASDAQ:ALHC - Free Report) in the 2nd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 117,396 shares of the company's stock, valued at approximately $2,795,000. Jefferies Financial Group Inc. owned 0.06% of Alignment Healthcare at the end of the most recent reporting period.

Other hedge funds have also modified their holdings of the company. Transamerica Financial Advisors LLC bought a new stake in Alignment Healthcare in the 2nd quarter valued at approximately $149,000. Corient Private Wealth LP acquired a new position in Alignment Healthcare during the 2nd quarter worth approximately $3,247,000. Odyssean LLC grew its stake in shares of Alignment Healthcare by 48.9% during the 2nd quarter. Odyssean LLC now owns 50,507 shares of the company's stock worth $1,203,000 after acquiring an additional 16,596 shares in the last quarter. Man Group plc bought a new position in shares of Alignment Healthcare during the 2nd quarter worth approximately $3,528,000. Finally, Jupiter Topco LLC acquired a new stake in shares of Alignment Healthcare in the second quarter valued at approximately $1,885,000. 86.19% of the stock is currently owned by institutional investors.

Wall Street Analyst Weigh In

ALHC has been the subject of several recent research reports. Raymond James Financial cut shares of Alignment Healthcare from a "strong-buy" rating to an "outperform" rating and reduced their target price for the stock from $22.00 to $19.00 in a report on Monday, August 3rd. UBS Group reiterated a "neutral" rating on shares of Alignment Healthcare in a research note on Wednesday, July 8th. Wall Street Zen cut shares of Alignment Healthcare from a "buy" rating to a "hold" rating in a research report on Saturday, August 1st. Barclays reduced their price objective on shares of Alignment Healthcare from $19.00 to $16.00 and set an "equal weight" rating for the company in a research note on Tuesday, May 26th. Finally, TD Cowen restated a "buy" rating on shares of Alignment Healthcare in a report on Monday, August 3rd. Seven research analysts have rated the stock with a Buy rating and four have assigned a Hold rating to the company's stock. Based on data from MarketBeat, the company presently has an average rating of "Moderate Buy" and a consensus price target of $23.60.

Insider Transactions at Alignment Healthcare

In other news, EVP Joseph S. Konowiecki sold 25,000 shares of the firm's stock in a transaction that occurred on Wednesday, July 1st. The stock was sold at an average price of $24.00, for a total value of $600,000.00. Following the completion of the sale, the executive vice president directly owned 1,103,816 shares of the company's stock, valued at $26,491,584. This trade represents a 2.21% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, President Dawn Christine Maroney sold 30,000 shares of Alignment Healthcare stock in a transaction that occurred on Monday, June 15th. The stock was sold at an average price of $19.55, for a total value of $586,500.00. Following the transaction, the president owned 947,313 shares of the company's stock, valued at $18,519,969.15. This represents a 3.07% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last ninety days, insiders have sold 1,009,951 shares of company stock valued at $18,597,287. Company insiders own 5.20% of the company's stock.

Alignment Healthcare Stock Performance

Shares of ALHC stock opened at $13.62 on Friday. The company has a fifty day moving average price of $18.09 and a two-hundred day moving average price of $18.53. Alignment Healthcare, Inc. has a one year low of $12.70 and a one year high of $25.12. The stock has a market cap of $2.83 billion, a P/E ratio of 71.69 and a beta of 1.10. The company has a debt-to-equity ratio of 1.22, a current ratio of 1.70 and a quick ratio of 1.70.

Alignment Healthcare (NASDAQ:ALHC - Get Free Report) last released its quarterly earnings data on Thursday, July 30th. The company reported $0.17 earnings per share for the quarter, topping the consensus estimate of $0.13 by $0.04. Alignment Healthcare had a net margin of 0.89% and a return on equity of 20.02%. The company had revenue of $1.34 billion for the quarter, compared to analyst estimates of $1.31 billion. During the same period in the previous year, the business earned $0.07 EPS. Alignment Healthcare's revenue for the quarter was up 31.6% compared to the same quarter last year. As a group, equities analysts predict that Alignment Healthcare, Inc. will post 0.17 EPS for the current year.

Alignment Healthcare Company Profile

Alignment Healthcare, Inc NASDAQ: ALHC is a health care company specializing in value-based care for Medicare Advantage beneficiaries. The company leverages an integrated care model that combines in-home clinical services, telehealth capabilities and digital health tools to manage chronic conditions, improve outcomes and enhance patient experience.

At the core of Alignment Healthcare's approach is a proprietary technology platform that aggregates real-time clinical and claims data to support preventive care, risk stratification and personalized care plans.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source